Gabelli & Co Investment Advisers’s Alder Biopharmaceuticals ALDR Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-703,703	Closed	-$13.3M	–	238
2019 Q3	$13.3M	Buy	+703,703	New	+$8.05M	1.49%	22

Gabelli & Co Investment Advisers's ALDR Position: Q4 2019 in Review

Gabelli & Co Investment Advisers sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 703,703 shares — an estimated $13.3M sold.

Gabelli & Co Investment Advisers first reported a position in ALDR in Q3 2019 and held it in 1 quarter. The position peaked at $13.3M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

Gabelli & Co Investment Advisers reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 703,703 Alder Biopharmaceuticals shares in Q4 2019, an estimated $13.3M.
Gabelli & Co Investment Advisers first reported a position in Alder Biopharmaceuticals in Q3 2019 and held it in 1 quarter.
Gabelli & Co Investment Advisers's Alder Biopharmaceuticals position peaked at $13.3M in Q3 2019.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2019, filed 14 Feb 2020.